Fierce Biotech November 30, 2023
If I had a nickel for each time in the past 48 hours a major medtech announced moves in heart implants aimed at reducing a person’s risk of stroke, I’d have two nickels.
Johnson & Johnson MedTech disclosed that it has spent $400 million upfront to purchase Laminar, the maker of a new type of device currently under development for closing off the heart’s left atrial appendage—a small, unnecessary pocket in the heart wall that, among people with an irregular heartbeat, can provide a place for potentially dangerous blood clots to form over time.
The company is the second this week to make news in the space, after Medtronic said Tuesday that the surgical, clip-based Penditure implant—acquired this...
Today's Sponsors
Today's Sponsor